Home » Proposed U.S. FDA Authority Over Lab-Developed Genetic Tests Worries Some
Proposed U.S. FDA Authority Over Lab-Developed Genetic Tests Worries Some
March 6, 2007
The U.S. Food and Drug Administration’s (FDA) proposal to regulate complex genetic laboratory-developed tests (LDTs) could stifle the development and marketing of new diagnostics, presenters said at a recent public meeting.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor